Windward Bio director gets 22,675 stock options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Windward Bio Group AG director David P. Bonita reported a grant of 22,675 stock options on November 12, 2026, with a $17-per-share exercise price and an expiration date of November 12, 2036. The options vest in 12 substantially equal monthly installments beginning December 31, 2026, subject to his continuous service on each vesting date. Under an agreement, Bonita is obligated to transfer securities issued under the options or their economic benefit to OrbiMed Advisors LLC, which will ensure they are provided to OrbiMed Private Investments IX, LP.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F1, F2 | 22,675 | $0.00 | $0.00 |
Footnotes (2)
- F1. This option will vest in 12 substantially equal monthly installments on the last day of the relevant month commencing on December 31, 2026, subject to the Reporting Person's continuous service as of each such vesting date.
- F2. Pursuant to an agreement with OrbiMed Advisors LLC, the Reporting Person is obligated to transfer any securities issued under any such stock options or other awards, or the economic benefit thereof to OrbiMed Advisors LLC, which will in turn ensure that such securities or economic benefits are provided to OrbiMed Private Investments IX, LP.
Key Figures
Key Terms
vest technical
continuous service technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many stock options did WWB director David P. Bonita receive?
AI-generated analysis. How Rhea-AI works. Not financial advice.